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COMMENT
The emerging need for family-centric initiatives
for obtaining consent in personal genome
research
Jusaku Minari1, Harriet Teare2, Colin Mitchell2, Jane Kaye2 and Kazuto Kato1,3*
Editorial summary
The use of information and communication technology
can offer a novel way to promote family-centric initiatives
for informed consent, and can address associated
ethical challenges in personal genome research.
There has been considerable debate on informed consent
in personal genome research. This includes, amongst
other things, the limitations of broad consent, the diffi-
culty of informed assent (for children to express their
willingness for research participation) and proxy consent,
and issues of consent for the creation and subsequent use
of cell lines such as HeLa cells [1-3]. The use of informa-
tion and communication technology (ICT) has been sug-
gested as one method to address some of these ethical
challenges, through an approach called ‘dynamic consent’,
which differs from conventional static consent by enabling
research participants to revisit their consent decisions
[4,5]. However, while dynamic consent mostly focuses on
the relationship between the researchers (or physicians)
and research participants, there has been less attention
given to its application to family-centric initiatives (FCIs).
Consideration of so-called family consent may shed light
on ways to address some of the developing ethical issues
that are relevant to personal genomic research.
The relevance of the family in genomic research
The central motivation for considering an FCI approach
for informed consent is the anxiety and subsequent debate
related to the return of clinically significant findings, in-
cluding ‘incidental findings’ obtained from research [6,7].
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As personal genome research is increasingly concerned
with whole genome sequence information, the findings
are potentially extensive and could have significant impact
for the research participant if disclosed. As an individual’s
genomic information is shared with family members, the
disclosure of those findings to research participants, in
some cases, would also have a considerable influence
on their families, specifically their blood relatives [8].
As shown by the concept of ‘mutuality’, which regards
a family ‘as a form of pooling and of spreading all known
risks’ [9], this family relationship can indirectly transform
family members into secondary research participants, or
stakeholders. Therefore, it is necessary to consider devel-
oping a framework for decision-making that addresses
mutuality, and the associated ethical ramifications.
The challenges of gaining informed consent from
family members
Compared with clinical settings [10], FCIs have not
really been considered and applied routinely in genomics
research. There are five key reasons for this. First, there
is the overriding belief that autonomy of the individual
is central to informed consent in genome research and
the decision whether to consent preferentially therefore
rests with the individual. As a result, the conventional
informed consent model is not designed to consider the
interests of different family members. Second, informed
consent procedures are not designed to capture the
views or preferences, or to record the decisions of other
family members, as they usually involve gaining the indi-
vidual’s signature at the start of research. This limits
how much informed consent procedures can reflect the
preferences of family members, who may not be present
when the consent form is signed, as there is currently no
requirement to consult other family members. Third, the
static nature of a paper consent form does not reflect
the complexity of decision-making that is required for
genomics, when findings may emerge over time as the
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research progresses. Fourth, there is the perceived prac-
tical and logistical burden of introducing the need to
contact and communicate with several family members,
some of whom may not know about the research study.
Fifth, new tools are now available through ICT (particu-
larly web 2.0) that can facilitate social interaction and
shared decision-making.
Family-centric initiatives using ICT
To address these challenges, rapid developments in ICT
could be harnessed to facilitate FCIs for consent in per-
sonal genome research. Using devices connected to the
web, individual research participants and their family
members could express their own views on research par-
ticipation of other family members in advance and also
in real time as the research progresses. This approach
could provide the opportunity for individuals to make an
informed choice on disclosure of research findings, in-
cluding clinically relevant incidental findings, and would
enable primary and secondary research participants to
hold different views on this. This is because an FCI ap-
proach based on dynamic consent using ICT would not
only have the capacity to flexibly manage various options
depending on different research contexts and personal
preferences, but would also provide the means for fam-
ilies to share and communicate about the findings. A
possible outcome would be that this approach could
facilitate the promotion of genome research, by creating
better relationships between stakeholders, particularly as
the relationship between research and clinical settings is
becoming increasingly blurred in the area of personal
genome research.
Challenges for implementation
There are several key challenges to enabling the practice
of a FCI approach using ICT. One is the definition of
the family; it is almost impossible to find a simple an-
swer across the world, because of the diversity of values
regarding a family. Another challenge is how to deal
with conflicting wishes of family members, how different
family members interact with one another, and any asso-
ciated hierarchies or fractious relationships that may be
exacerbated within the research context. In some cases,
in terms of privacy and autonomy, the FCI approach
could undermine the right for research participants to
participate in research projects and to control their own
genome information if their families’ interests were con-
sidered. It also raises the possibility of coercion - the re-
search project would need to be managed in such a way as
to allow family members to express their views confiden-
tially without having to disclose to their relatives whether
or not they had agreed to participate.
The introduction of ICT could address many of the lo-
gistical difficulties associated with FCIs, and thus provide
a platform to identify some of the more complex and
emotional issues. By providing effective methods to con-
vey a range of information regarding research projects in a
variety of formats, this may help to collect opinions and
ease conflicts between family members. Therefore, in
designing an ICT system before the implementation of a
research project, the identification of relevant family
members and the establishment of procedures for their
decision-making, incorporating conventional careful face-
to-face communication, would play a crucial role in the
effectiveness of FCIs. Bespoke design would also enable
different cultural norms and the specificities of social con-
texts to be taken into account.
Ultimately, novel and alternative approaches, moving
away from traditional, front-loaded informed consent,
have the potential to further facilitate research progress
and promote public trust in research. They can also
address the emerging importance of the family in perso-
nal genome research, due to an increased awareness of
clinically significant findings and the unique nature of
genome information shared between family members.
By providing a direct communication channel it will be
easier to consider the views of family members who
could be affected by the return of incidental research
findings. We anticipate that the FCI approach would not
necessarily be appropriate for all research projects, but it
would have significant benefits for broad research con-
texts, including family-based study, pediatric research
and genome cohorts, such as a three-generation co-
hort study.
Conclusions
A FCI approach using ICT may raise new technical,
financial and social challenges, but it would also deliver
novel benefits, through dynamic communication, for
several stakeholders, including research participants and
their families, researchers, ethics review committees and
genetic counsellors. The feasibility of the FCI-based
consent with ICT can be reinforced by the possibilities
of introducing digital interfaces to facilitate digital or
e-governance in biomedical research. It might be applic-
able not only to other biomedical research but also more
widely in the clinic, including for genetic testing, organ
donation and cancer notification.
For FCI consent to work using a dynamic consent
approach, it could require engagement of ICT across dif-
ferent generations in one family. It will be important to
ensure that mechanisms are in place for individuals who
are not familiar with, or comfortable using, ICT to con-
tribute their views. Further studies that explore the use of
ICT across generations, and that recognize cultural differ-
ences and can learn from diverse approaches to the family,
will help to further explore and develop the possibility of
applying an FCI approach usefully in biomedical research.
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